http://rdf.ncbi.nlm.nih.gov/pubchem/reference/35912523
Outgoing Links
Predicate
Object
contentType
Journal Article
endingPage
1337
issn
0140-6736
issueIdentifier
10385
pageRange
1336-1337
publicationName
Lancet (London, England)
startingPage
1336
bibliographicCitation
Kjeldsen SE, Burnier M, Narkiewicz K, Kreutz R, Mancia G. Key questions regarding the SYMPLICITY HTN-3 trial. Lancet. 2023 Apr 22;401(10385):1336–7. doi: 10.1016/s0140-6736(23)00340-9. PMID: 37087164.
creator
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_20ebb78cacdb67f1606514cb6bc0e7ac
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5c397d927687dd8228abcd53199184a2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1b76f5ff2702e85674d70c85e1fbfc5f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7acd64f04a75322a35d00a0d7ff4276f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d29872a9e31b5411628b46133fd86fe3
date
2023-04-22-04:00
^^<
http://www.w3.org/2001/XMLSchema#date
>
identifier
https://pubmed.ncbi.nlm.nih.gov/37087164
https://doi.org/10.1016/s0140-6736%2823%2900340-9
isPartOf
https://portal.issn.org/resource/ISSN/0140-6736
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5470
language
English
source
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title
Key questions regarding the SYMPLICITY HTN-3 trial
discusses
http://id.nlm.nih.gov/mesh/M0001456
hasPrimarySubjectTerm
http://id.nlm.nih.gov/mesh/D006973Q000188
hasSubjectTerm
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D013562
http://id.nlm.nih.gov/mesh/D000959Q000627
http://id.nlm.nih.gov/mesh/D001794
http://id.nlm.nih.gov/mesh/D007668
Total number of triples:
29
.